212 related articles for article (PubMed ID: 37435257)
61. Despite expert recommendations, second-generation antipsychotics are not often prescribed in the emergency department.
Wilson MP; Minassian A; Bahramzi M; Campillo A; Vilke GM
J Emerg Med; 2014 Jun; 46(6):808-13. PubMed ID: 24656982
[TBL] [Abstract][Full Text] [Related]
62. Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study.
Battaglia J; Moss S; Rush J; Kang J; Mendoza R; Leedom L; Dubin W; McGlynn C; Goodman L
Am J Emerg Med; 1997 Jul; 15(4):335-40. PubMed ID: 9217519
[TBL] [Abstract][Full Text] [Related]
63. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia.
Wright P; Birkett M; David SR; Meehan K; Ferchland I; Alaka KJ; Saunders JC; Krueger J; Bradley P; San L; Bernardo M; Reinstein M; Breier A
Am J Psychiatry; 2001 Jul; 158(7):1149-51. PubMed ID: 11431240
[TBL] [Abstract][Full Text] [Related]
64. [New formulations of olanzapine in the treatment of acute agitation].
Bartkó G
Neuropsychopharmacol Hung; 2006 Dec; 8(4):171-8. PubMed ID: 17211052
[TBL] [Abstract][Full Text] [Related]
65. Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine.
TREC Collaborative Group
BMJ; 2003 Sep; 327(7417):708-13. PubMed ID: 14512476
[TBL] [Abstract][Full Text] [Related]
66. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
67. Intramuscular olanzapine in the management of acute agitation.
Tulloch KJ; Zed PJ
Ann Pharmacother; 2004 Dec; 38(12):2128-35. PubMed ID: 15522977
[TBL] [Abstract][Full Text] [Related]
68. A prospective naturalistic multicenter study on choice of parenteral medication in psychiatric emergency settings in Japan.
Hatta K; Katayama S; Morikawa F; Imai A; Fujita K; Fujita A; Ishizuka T; Abe T; Sudo Y; Hashimoto K; Usui C; Nakamura H; Yamanouchi Y; Hirata T;
Neuropsychopharmacol Rep; 2018 Sep; 38(3):117-123. PubMed ID: 30175524
[TBL] [Abstract][Full Text] [Related]
69. Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation.
Villari V; Rocca P; Fonzo V; Montemagni C; Pandullo P; Bogetto F
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):405-13. PubMed ID: 17900775
[TBL] [Abstract][Full Text] [Related]
70. The Characteristics and Prevalence of Agitation in an Urban County Emergency Department.
Miner JR; Klein LR; Cole JB; Driver BE; Moore JC; Ho JD
Ann Emerg Med; 2018 Oct; 72(4):361-370. PubMed ID: 30031556
[TBL] [Abstract][Full Text] [Related]
71. A naturalistic comparison of the efficacy and safety of intramuscular olanzapine and intramuscular haloperidol in agitated elderly patients with schizophrenia.
Suzuki H; Gen K; Takahashi Y
Ther Adv Psychopharmacol; 2013 Dec; 3(6):314-21. PubMed ID: 24294484
[TBL] [Abstract][Full Text] [Related]
72. Conventional intramuscular sedatives versus ziprasidone for severe agitation in adolescents: case-control study.
Jangro WC; Preval H; Southard R; Klotz SG; Francis A
Child Adolesc Psychiatry Ment Health; 2009 Mar; 3(1):9. PubMed ID: 19284622
[TBL] [Abstract][Full Text] [Related]
73. Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation.
Baker RW; Kinon BJ; Maguire GA; Liu H; Hill AL
J Clin Psychopharmacol; 2003 Aug; 23(4):342-8. PubMed ID: 12920409
[TBL] [Abstract][Full Text] [Related]
74. Rapid Agitation Control With Ketamine in the Emergency Department: A Blinded, Randomized Controlled Trial.
Barbic D; Andolfatto G; Grunau B; Scheuermeyer FX; Macewan B; Qian H; Wong H; Barbic SP; Honer WG
Ann Emerg Med; 2021 Dec; 78(6):788-795. PubMed ID: 34353650
[TBL] [Abstract][Full Text] [Related]
75. Olanzapine for injection: new formulation. No advantage in agitated patients.
Prescrire Int; 2004 Jun; 13(71):92-3. PubMed ID: 15233144
[TBL] [Abstract][Full Text] [Related]
76. [Haloperidol plus promethazine for agitated patients--a systematic review].
Huf G; Coutinho ES; Adams CE
Braz J Psychiatry; 2009 Sep; 31(3):265-70. PubMed ID: 19784494
[TBL] [Abstract][Full Text] [Related]
77. [Prescription of olanzapine in children and adolescent psychiatric patients].
Frémaux T; Reymann JM; Chevreuil C; Bentué-Ferrer D
Encephale; 2007; 33(2):188-96. PubMed ID: 17675914
[TBL] [Abstract][Full Text] [Related]
78. Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia.
Kinon BJ; Roychowdhury SM; Milton DR; Hill AL
J Clin Psychiatry; 2001; 62 Suppl 2():17-21. PubMed ID: 11232746
[TBL] [Abstract][Full Text] [Related]
79. Olanzapine in ED patients: differential effects on oxygenation in patients with alcohol intoxication.
Wilson MP; Chen N; Vilke GM; Castillo EM; MacDonald KS; Minassian A
Am J Emerg Med; 2012 Sep; 30(7):1196-201. PubMed ID: 22633728
[TBL] [Abstract][Full Text] [Related]
80. Evidence-Based Review of Pharmacotherapy for Acute Agitation. Part 1: Onset of Efficacy.
Zun LS
J Emerg Med; 2018 Mar; 54(3):364-374. PubMed ID: 29361326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
